Skip to main content
. 2022 Apr 11;20:26. doi: 10.1186/s12969-022-00680-z

Table 2.

Comparison of Th17- and regulatory T cells-specific markers in peripheral CD4+ helper T cells

Gate Subpopulation JIA HC p-value
CD4+ CCR6+ 8.01 ± 4.35 (7.25; 1.40–16.60) 1.80 ± 0.90 (1.60; 0.90–3.20) 0.011
CD4+ CD161+ 7.06 ± 4.70 (6.30; 1.00–14.40) 1.98 ± 1.19 (2.70; 0.40–2.90) 0.011
CD4+

CCR6+

CD161+

0.85 ± 0.60 (0.70; 0.20–1.80) 0.08 ± 0.08 (0.10; 0.00–0.20) 0.002*
CD4+ RORγt+ 0.58 ± 0.43 (0.45; 0.30–1.60) 1.06 ± 0.53 (1.00; 0.50–1.70) 0.045
CD4+ IL-17+ 1.10 ± 0.79 (0.80; 0.50–2.90) 0.24 ± 0.09 (0.30; 0.10–0.30) 0.002*
CD4+RORγt+ IL-17+ 7.48 ± 3.74 (7.30; 2.20–13.10) 2.54 ± 2.46 (1.00; 0.60–6.00) 0.019
CD4+ FoxP3+ 3.59 ± 1.82 (3.25; 1.70–6.50) 2.26 ± 1.01 (2.30; 1.10–3.30) 0.171
CD4+FoxP3+ IL-17+ 3.10 ± 1.43 (2.85; 1.20–5.60) 0.62 ± 0.23 (0.60; 0.40–1.00) 0.002*
CD4+FoxP3+

CD25+

CD127

24.94 ± 10.79 (24.45; 8.30–41.20) 24.00 ± 4.83 (22.40; 18.50–30.80) 1.000

Peripheral blood mononuclear cells were assessed for Th17- and regulatory T cells (Treg)-characteristic markers by flow cytometry. Values of 5 healthy controls (HC) and 8 patients with Juvenile Idiopathic Arthritis (JIA) were compared with Mann–Whitney-U-test. Data are presented as percentages in mean ± standard deviation (median; minimum—maximum). After correction for multiple comparison with Bonferroni correction the results marked with * remained statistically significant. Elevated proportions of Th17/Th1 switching cells as well as CD4+ and CD4+ FoxP3+ cells producing IL-17 were assessed in JIA patients compared to HC